{"organizations": [], "uuid": "07f322bd0360030d1aeab43f7ec6da2ea19cfb4c", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000551/device/rss", "section_title": "California", "url": "https://www.cnbc.com/2018/03/09/the-associated-press-chemocentryx-posts-4q-profit.html", "country": "US", "domain_rank": 767, "title": "ChemoCentryx posts 4Q profit", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-09T14:41:00.000+02:00", "replies_count": 0, "uuid": "07f322bd0360030d1aeab43f7ec6da2ea19cfb4c"}, "author": "cnbc.com", "url": "https://www.cnbc.com/2018/03/09/the-associated-press-chemocentryx-posts-4q-profit.html", "ord_in_thread": 0, "title": "ChemoCentryx posts 4Q profit", "locations": [], "entities": {"persons": [], "locations": [{"name": "calif.", "sentiment": "none"}, {"name": "mountain view", "sentiment": "none"}], "organizations": [{"name": "chemocentryx", "sentiment": "negative"}, {"name": "chemocentryx inc.", "sentiment": "negative"}, {"name": "ccxi", "sentiment": "negative"}, {"name": "ap", "sentiment": "negative"}, {"name": "zacks investment research", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "MOUNTAIN VIEW, Calif. (AP) _ ChemoCentryx Inc. (CCXI) on Friday reported fourth-quarter net income of $39.7 million, after reporting a loss in the same period a year earlier.\nThe Mountain View, California-based company said it had profit of 80 cents per share.\nThe biopharmaceutical company posted revenue of $56.3 million in the period.\nFor the year, the company reported net income of $17.9 million, or 36 cents per share, swinging to a profit in the period. Revenue was reported as $82.5 million.\nChemoCentryx shares have risen 83 percent since the beginning of the year. The stock has risen 63 percent in the last 12 months.\nThis story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on CCXI at https://www.zacks.com/ap/CCXI", "external_links": [], "published": "2018-03-09T14:41:00.000+02:00", "crawled": "2018-03-09T18:11:15.002+02:00", "highlightTitle": ""}